KC
ELV icon

Kenfarb & Co’s Elevance Health ELV Stock Holding History

Kenfarb & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$27K Hold
62
– – 0.02% 151
2023
Q2 		$27.5K Hold
62
– – 0.02% 151
2023
Q1 		$28.5K Hold
62
– – 0.03% 147
2022
Q4 		$31.8K Hold
62
– – 0.03% 150
2022
Q3 		$28K Buy
+62
New +$29.7K 0.03% 151

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kenfarb & Co's ELV Position: Q3 2023 in Review

Kenfarb & Co held its Elevance Health (ELV) position steady in Q3 2023 at 62 shares worth $27K. The position accounts for 0.02% of the portfolio, ranked #151.

Kenfarb & Co first reported a position in ELV in Q3 2022 and has held it in 5 quarters since. The position peaked at $31.8K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Kenfarb & Co held 62 shares of Elevance Health worth $27K as of Q3 2023.
  • Kenfarb & Co left its Elevance Health share count unchanged in Q3 2023.
  • Elevance Health made up 0.02% of Kenfarb & Co's portfolio in Q3 2023, its #151 holding.
  • Kenfarb & Co first reported a position in Elevance Health in Q3 2022 and has held it in 5 quarters since.
  • Kenfarb & Co's Elevance Health position peaked at $31.8K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.